The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Ketamine Decreases Resting State Functional Network Connectivity in Healthy Subjects: Implications for Antidepressant Drug Action
Open accessAbstract
Increasing preclinical and clinical evidence underscores the strong and rapid antidepressant properties of the glutamate-modulating NMDA receptor antagonist ketamine. Targeting the glutamatergic system might thus provide a novel molecular strategy for antidepressant treatment. Since glutamate is the most abundant and major excitatory neurotransmitter in the brain, pathophysiological changes in glutamatergic signaling are likely to affect neurobehavioral plasticity, information processing and large-scale changes in functional brain connectivity underlying certain symptoms of major depressive disorder. Using resting state functional magnetic resonance imaging (rsfMRI), the "dorsal nexus "(DN) was recently identified as a bilateral dorsal medial prefrontal cortex region showing dramatically increased depression-associated functional connectivity with large portions of a cognitive control network (CCN), the default mode network (DMN), and a rostral affective network (AN). Hence, Sheline and colleagues (2010) proposed that reducing increased connectivity of the DN might play a critical role in reducing depression symptomatology and thus represent a potential therapy target for affective disorders. Here, using a randomized, placebo-controlled, double-blind, crossover rsfMRI challenge in healthy subjects we demonstrate that ketamine decreases functional connectivity of the DMN to the DN and to the pregenual anterior cingulate (PACC) and medioprefrontal cortex (MPFC) via its representative hub, the posterior cingulate cortex (PCC). These findings in healthy subjects may serve as a model to elucidate potential biomechanisms that are addressed by successful treatment of major depression. This notion is further supported by the temporal overlap of our observation of subacute functional network modulation after 24 hours with the peak of efficacy following an intravenous ketamine administration in treatment-resistant depression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“That such changes of RSFC after interventions of antidepressant action can also be observed in healthy subjects was recently supported by a finding from Scheidegger and colleagues [68], who showed that, similar to our finding, a connectivity decrease of anterior and posterior DMN components, located in pgACC and PCC, was observed after 24 hrs of ketamine injection, mirroring the substances'”
From State and training effects of mindfulness meditation on brain networks reflect neuronal mechanisms of its antidepressant effect (2016) · cites this paper as [68]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“These findings were complemented by data showing that 8 weeks of sertraline treatment normalized amygdalar hyper-activation to sad faces in MDD [194], replicating prior findings [195,196].”
From Prefrontal cortex and depression (2022) · cites this paper as [194]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1970) · Cited by 24,983
Tzourio-Mazoyer, N., Landeau, B., Papathanassiou, D., Crivello, F., Etard, O., Delcroix, N., Mazoyer, B., & Joliot, M. (2002) · NeuroImage · doi:10.1006/nimg.2001.0978 · Cited by 16,319 · cited 1×
“Since in a recent study, decreased connectivity of the amygdala to prefrontal areas has been shown following antidepressant treatment [48], we further included anatomically defined ROIs for left and right amygdala, taken from the Automated Anatomical Labeling (AAL) atlas [55].”
MethodA default mode of brain function
Raichle, M. E., MacLeod, A. M., Snyder, A. Z., Powers, W. J., Gusnard, D. A., & Shulman, G. L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.2.676 · Cited by 12,190 · cited 2×
“Specifically in depressed patients, altered negative BOLD responses in the default mode network (DMN) [37] could be found during emotional processing tasks [38,39], with decreased negative BOLD signal amplitudes being positively correlated with lower glutamate concentrations within the pregenual anterior cingulate cor…”
BackgroundThe Brain's Default Network: Anatomy, Function, and Relevance to Disease
Buckner, R. L., Andrews‐Hanna, J. R., & Schacter, D. L. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1440.011 · Cited by 9,761
Deep Brain Stimulation for Treatment-Resistant Depression
Mayberg, H. S., Lozano, A. M., Voon, V., McNeely, H. E., Seminowicz, D., Hamani, C., Schwalb, J. M., & Kennedy, S. H. (2005) · Neuron · doi:10.1016/j.neuron.2005.02.014 · Cited by 4,059 · cited 1×
“Moreover, the sgACC as a critical hub of the AN plays an important role in emotion processing and the pathogenesis of mood disorders and has become a promising target for deep brain stimulation in patients with severe, refractory depression [65].”
BackgroundAntidepressant effects of ketamine in depressed patients
Berman, R. M., Cappiello, A., Anand, A., Oren, D. A., Heninger, G. R., Charney, D. S., & Krystal, J. H. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00230-9 · Cited by 3,856 · cited 1×
“Based on the increasing evidence of glutamate-modulating agents having strong and rapid antidepressant properties [1,2], the NMDA receptor antagonist ketamine has been firmly established as a research tool for the investigation of the neurobiology of the glutamatergic system in major depressive disorder (MDD) and nove…”
BackgroundA randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.
Zarate, C. A., Singh, J. B., Carlson, P. J., Brutsche, N. E., Ameli, R., Luckenbaugh, D. A., Charney, D. S., & Manji, H. K. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.8.856 · Cited by 3,766
DPARSF: a MATLAB toolbox for “pipeline” data analysis of resting-state fMRI
Yan (2010) · Frontiers in System Neuroscience · doi:10.3389/fnsys.2010.00013 · Cited by 3,475
Functional and Effective Connectivity: A Review
Friston, K. J. (2011) · Brain Connectivity · doi:10.1089/brain.2011.0008 · Cited by 3,415 · cited 1×
“Recent advances in resting state functional connectivity neuroimaging techniques suggest their utility for the investigation of (1) intrinsic brain connections in the healthy human brain, (2) pathophysiological alterations in disease states and (3) changes in neuronal network dynamics following therapeutic interventio…”
BackgroundInfluentialmTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists
Li, N., Lee, B., Liu, R.-J., Banasr, M., Dwyer, J. M., Iwata, M., Li, X.-Y., Aghajanian, G., & Duman, R. S. (2010) · Science · doi:10.1126/science.1190287 · Cited by 2,881
Cited by
Duman, R. S., Sanacora, G., & Krystal, J. H. (2019) · Neuron · doi:10.1016/j.neuron.2019.03.013 · Cited by 1,026
“Studies in healthy controls are also consistent with the hypothesis that ketamine enhances GABA inhibition, reporting that ketamine decreases DMN connectivity and reduces reactivity of amygdala-hippocampal circuity in response to emotional stimuli (Evans et al., 2018; Scheidegger et al., 2016; Scheidegger et al., 2012…”
ResultPrefrontal cortex and depression
Pizzagalli, D. A., & Roberts, A. C. (2022) · Neuropsychopharmacology · doi:10.1038/s41386-021-01101-7 · Cited by 667
“These findings were complemented by data showing that 8 weeks of sertraline treatment normalized amygdalar hyper-activation to sad faces in MDD [194], replicating prior findings [195, 196].”
ResultPsilocybin for treatment-resistant depression: fMRI-measured brain mechanisms
Carhart-Harris, R. L., Roseman, L., Bolstridge, M., Demetriou, L., Pannekoek, J. N., Wall, M. B., Tanner, M., Kaelen, M., McGonigle, J., Murphy, K., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-13282-7 · Cited by 587
Functional reorganization of the default mode network across chronic pain conditions
Baliki, M. N., Mansour, A. R., Baria, A. T., & Apkarian, A. V. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106133 · Cited by 532
“For example, it has been shown that ketamine (an anti-depressant drug) decreases functional connectivity of the DMN to the MPFC in healthy subjects [55].”
BackgroundDepression, Neuroimaging and Connectomics: A Selective Overview
Gong, Q., & He, Y. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.08.009 · Cited by 496
“was tested by R-fMRI studies in healthy individuals: the MPFC exhibited reduced functional connectivity following a ketamine and SSRI (citalopram) administration (121-123).”
Metadata
- Authors
- Scheidegger, M., Walter, M., Lehmann, M., Metzger, C., Grimm, S., Boeker, H., Boesiger, P., Henning, A., & Seifritz, E.
- Affiliations
- ETH Zurich (CH)
- Center for Behavioral Brain Sciences (DE)
- Psychiatrische Universitätsklinik Zürich (CH)
- University of Zurich (CH)
- Corresponding author
- Scheidegger, Milan
- Walter, Martin
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-09-24
- Volume
- 7
- Issue
- 9
- Pages
- e44799
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3461985
- OpenAlex
- W1964807622
- Cited by
- 282
- References
- 68
- Citations by year
- 2026: 15 · 2025: 15 · 2024: 16 · 2023: 13 · 2022: 19 · 2021: 21 · 2020: 13 · 2019: 26 · 2018: 21 · 2017: 17 · 2016: 36 · 2015: 25 · 2014: 27 · 2013: 18
- FWCI
- 16.47
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Max Planck Digital Library (submittedVersion)
- MPG.PuRe (Max Planck Society) (submittedVersion)
- Repository for Publications and Research Data (ETH Zurich) (submittedVersion, cc-by)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion, cc-by)
- ETH Zürich Research Collection (cc-by)
- Zurich Open Repository and Archive (University of Zurich)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cognitive Neuroscience › Functional Brain Connectivity Studies
- Life Sciences › Neuroscience › Neurology › Transcranial Magnetic Stimulation Studies
- Keywords
- ketamine, resting-state functional connectivity, major depressive disorder, default mode network, posterior cingulate cortex, pregenual anterior cingulate cortex, glutamatergic system, NMDA receptor antagonists, antidepressant mechanism, treatment-resistant depression, cognitive control network
- MeSH terms
- Adult, Antidepressive Agents, Brain Mapping, Major Depressive Disorder, Double-Blind Method, Female, Gyrus Cinguli, Humans, Injections, Intravenous, Ketamine, Magnetic Resonance Imaging, Male, Middle Aged, Neural Pathways, Placebos, Septal Nuclei, Prefrontal Cortex, Cross-Over Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Ketamine Decreases Resting State Functional Network Connectivity in Healthy Subjects: Implications for Antidepressant Drug Action. https://app.cochat.ai/papers/10.1371/journal.pone.0044799
- The paper
- Scheidegger, M., Walter, M., Lehmann, M., Metzger, C., Grimm, S., Boeker, H., Boesiger, P., Henning, A., & Seifritz, E. (2012). Ketamine Decreases Resting State Functional Network Connectivity in Healthy Subjects: Implications for Antidepressant Drug Action. PLoS ONE. https://doi.org/10.1371/journal.pone.0044799
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.